FindTrial
Sign In

Efficacy and safety of bimatoprost 0.01% for the treatment of eyebrow hypotrichosis: A randomized, double-blind, vehicle-controlled study

Efficacy and safety of bimatoprost 0.01% for the treatment of eyebrow hypotrichosis: A randomized, double-blind, vehicle-controlled study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160911001
Enrollment
40
Registered
2016-09-11
Start date
2016-07-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eyebrow hypotrichosis Madarosis

Interventions

Topical 0.01% bimatoprost solution,Placebo
Experimental Drug,Placebo Comparator Drug

Sponsors

Division of Dermatology, Ramathibodi Hospital, Mahidol University
Lead Sponsor
Division of Dermatology&#44
Collaborator
Ramathibodi Hospital&#44
Collaborator
Mahidol University
Collaborator

Eligibility

Sex/Gender
All
Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Healthy male and female subject 2.Diagnosis of eyebrow hypotrichosis 3.Agree to participate and signed informed consent form

Exclusion criteria

Exclusion criteria: 1.History of eyebrow transplant 2.Applying topical hair growth products within 2 weeks 3.Receiving light and laser treatment of the eyebrow within 3 months 4.Taking oral medication influenced hair within 6 months 5.History of systemic illness 6.Pregnancy or breast feeding

Design outcomes

Primary

MeasureTime frame
Efficacy of topical 0.01% bimatoprost solution 6 months Hair count and hair diameter—

Secondary

MeasureTime frame
Safety of topical 0.01% bimatoprost solution 6 months Erythema, Scaliness, Inflammation and Hyperpigmentation—

Countries

Thailand

Contacts

Public ContactPoonkiat Suchonwanit

Ramathibodi Hospital, Mahidol University

poonkiat@hotmail.com0817348580

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026